The global Cell and Gene Therapy Manufacturing Services Market is entering a transformative era, with its value projected to surge from USD 11.4 billion in 2023 to an astounding USD 70.7 billion by 2032, expanding at a compound annual growth rate (CAGR) of 22.4% over the forecast period from 2024 to 2032. This rapid expansion reflects the sector's growing significance in the development and...